The National Institute for Health Research (NIHR) has issued a press release highlighting its major investments into research into challenges such as antimicrobial resistance.
The £58.7 million invested has been used to create 14 Health Protection Research Units (HPRUs) focussed on fields such as:
- Antimicrobial resistance (AMR)
- Vaccines and immunisation
- Modelling and health economics
Public Health England (PHE) will continue its work with the data NIHR create to help reduce the impact of threats to the public. The funding is designed to enhance “the ability of PHE to use innovative techniques to protect the public’s health and minimise the health impact of emergencies”.
Nicola Blackwood, Health Minister, said:
“The UK’s achievements in public health to date have saved the lives of millions of people. This would have been impossible without world-leading research conducted by some of the brightest minds up and down the country.
“The latest round of NIHR’s Health Protection Research Units, which have previously played a pivotal role in responding to major events such as the Novichok and Ebola incidents, will continue to protect the health of the public and reduce inequalities – helping us all live healthier lives.”
The Medical Director of PHE, Prof Yvonne Doyle, said:
“Tackling major public health threats such as antimicrobial resistance, emerging infections and air pollution requires innovative, collaborative research. Our partnerships with leading universities play a critical role in building the science that keeps us safe – not just from current threats, but the health challenges of tomorrow.”
Find out more about the HPRUs here.